Loading…
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Degasperi, Elisabetta, Colombo, Massimo
Published in The lancet. Gastroenterology & hepatology (01.10.2016)
Published in The lancet. Gastroenterology & hepatology (01.10.2016)
Get more information
Journal Article
Loading…
Loading…
Direct-acting antivirals: the endgame for hepatitis C?
D’Ambrosio, Roberta, Degasperi, Elisabetta, Colombo, Massimo, Aghemo, Alessio
Published in Current opinion in virology (01.06.2017)
Published in Current opinion in virology (01.06.2017)
Get full text
Journal Article
Loading…
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy
Tosetti, Giulia, Degasperi, Elisabetta, Farina, Elisa, D'Ambrosio, Roberta, Soffredini, Roberta, Borghi, Marta, La Mura, Vincenzo, Primignani, Massimo, Lampertico, Pietro
Published in The American journal of gastroenterology (01.06.2021)
Published in The American journal of gastroenterology (01.06.2021)
Get full text
Journal Article
Loading…
The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)
D'Ambrosio, Roberta, Campi, Irene, Maggioni, Marco, Perbellini, Riccardo, Giammona, Enza, Stucchi, Roberta, Borghi, Marta, Degasperi, Elisabetta, De Silvestri, Annalisa, Persani, Luca, Fugazzola, Laura, Lampertico, Pietro
Published in PloS one (06.04.2021)
Published in PloS one (06.04.2021)
Get full text
Journal Article
Loading…
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Wong, Yu Jun, Zhaojin, Chen, Tosetti, Guilia, Degasperi, Elisabetta, Sharma, Sanchit, Agarwal, Samagra, Chuan, Liu, Huak, Chan Yiong, Jia, Li, Xiaolong, Qi, Saraya, Anoop, Primignani, Massimo
Published in Clinical and molecular hepatology (01.01.2023)
Published in Clinical and molecular hepatology (01.01.2023)
Get full text
Journal Article
Loading…
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon
D’Ambrosio, Roberta, Degasperi, Elisabetta, Aghemo, Alessio, Fraquelli, Mirella, Lampertico, Pietro, Rumi, Maria Grazia, Facchetti, Floriana, Grassi, Eleonora, Casazza, Giovanni, Rosenberg, William, Bedossa, Pierre, Colombo, Massimo
Published in PloS one (01.06.2016)
Published in PloS one (01.06.2016)
Get full text
Journal Article
Loading…
Treatment of Extrahepatic Manifestations of Hepatitis C Virus
Degasperi, Elisabetta, Aghemo, Alessio, Colombo, Massimo
Published in Clinics in liver disease (01.08.2017)
Published in Clinics in liver disease (01.08.2017)
Get more information
Journal Article
Loading…
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Graf, Christiana, D’Ambrosio, Roberta, Degasperi, Elisabetta, Paolucci, Stefania, Llaneras, Jordi, Vermehren, Johannes, Dultz, Georg, Peiffer, Kai-Henrik, Finkelmeier, Fabian, Herrmann, Eva, Zeuzem, Stefan, Buti, Maria, Lampertico, Pietro, Dietz, Julia, Sarrazin, Christoph
Published in JHEP reports (01.03.2024)
Published in JHEP reports (01.03.2024)
Get full text
Journal Article
Loading…
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
Anolli, Maria Paola, Uceda Renteria, Sara, Degasperi, Elisabetta, Facchetti, Floriana, Sambarino, Dana, Borghi, Marta, Perbellini, Riccardo, Soffredini, Roberta, Monico, Sara, Callegaro, Annapaola, Lampertico, Pietro
Published in JHEP reports (01.03.2025)
Published in JHEP reports (01.03.2025)
Get full text
Journal Article
Loading…
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
Shekhtman, Louis, Cotler, Scott J., Degasperi, Elisabetta, Anolli, Maria Paola, Uceda Renteria, Sara Colonia, Sambarino, Dana, Borghi, Marta, Perbellini, Riccardo, Facchetti, Floriana, Ceriotti, Ferruccio, Lampertico, Pietro, Dahari, Harel
Published in JHEP reports (01.02.2024)
Published in JHEP reports (01.02.2024)
Get full text
Journal Article
Loading…
Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy
Tan-Garcia, Alfonso, Lai, Fritz, Yeong, Joe Poh Sheng, Irac, Sergio E., Ng, Pei Y., Msallam, Rasha, Lim, Jeffrey Chun Tatt, Wai, Lu-En, Tham, Christine Y.L., Choo, Su P., Lim, Tony, Young, Dan Y., D'Ambrosio, Roberta, Degasperi, Elisabetta, Perbellini, Riccardo, Newell, Evan, Le Bert, Nina, Ginhoux, Florent, Bertoletti, Antonio, Chen, Qingfeng, Dutertre, Charles-Antoine
Published in JHEP reports (01.02.2020)
Published in JHEP reports (01.02.2020)
Get full text
Journal Article
Loading…
Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir
Aghemo, Alessio, Grassi, Eleonora, Rumi, Maria Grazia, D'Ambrosio, Roberta, Galmozzi, Enrico, Degasperi, Elisabetta, Castaldi, Davide, Soffredini, Roberta, Colombo, Massimo
Published in PloS one (01.04.2014)
Published in PloS one (01.04.2014)
Get full text
Journal Article
Loading…
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study
Valenti, Luca, Pelusi, Serena, Aghemo, Alessio, Gritti, Sara, Pasulo, Luisa, Bianco, Cristiana, Iegri, Claudia, Cologni, Giuliana, Degasperi, Elisabetta, D’Ambrosio, Roberta, Poggio, Paolo, Soria, Alessandro, Puoti, Massimo, Carderi, Isabella, Pigozzi, Marie Graciella, Carriero, Canio, Spinetti, Angiola, Zuccaro, Valentina, Memoli, Massimo, Giorgini, Alessia, Viganò, Mauro, Rumi, Maria Grazia, Re, Tiziana, Spinelli, Ombretta, Colombo, Maria Chiara, Quirino, Tiziana, Menzaghi, Barbara, Lorini, Gianpaolo, Pan, Angelo, D’Arminio Monforte, Antonella, Buscarini, Elisabetta, Autolitano, Aldo, Bonfanti, Paolo, Terreni, Natalia, Aimo, Gianpiero, Mendeni, Monia, Prati, Daniele, Lampertico, Pietro, Colombo, Massimo, Fagiuoli, Stefano
Published in Hepatology communications (01.04.2022)
Published in Hepatology communications (01.04.2022)
Get full text
Journal Article
Loading…
PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history
Degasperi, Elisabetta, Viganò, Mauro, Aghemo, Alessio, Lampertico, Pietro, Colombo, Massimo
Published in Expert review of anti-infective therapy (01.05.2013)
Published in Expert review of anti-infective therapy (01.05.2013)
Get full text
Journal Article
Loading…
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
Degasperi, Elisabetta, Anolli, Maria Paola, Lampertico, Pietro
Published in Journal of viral hepatitis (01.04.2023)
Published in Journal of viral hepatitis (01.04.2023)
Get full text
Journal Article
Loading…
Advances in hepatitis delta research: emerging insights and future directions
Degasperi, Elisabetta, Anolli, Maria Paola, Lampertico, Pietro
Published in Sexually transmitted infections (01.08.2024)
Published in Sexually transmitted infections (01.08.2024)
Get full text
Journal Article
Loading…
HDV RNA and liver disease progression: What do we know?
Stockdale, Alexander J., Degasperi, Elisabetta
Published in Hepatology (Baltimore, Md.) (01.05.2024)
Published in Hepatology (Baltimore, Md.) (01.05.2024)
Get full text
Journal Article
Loading…
Bulevirtide for patients with compensated chronic hepatitis delta: A review
Degasperi, Elisabetta, Anolli, Maria P., Lampertico, Pietro
Published in Liver international (01.08.2023)
Published in Liver international (01.08.2023)
Get full text
Journal Article
Loading…
Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?
Tosetti, Giulia, Degasperi, Elisabetta, Farina, Elisa, Primignani, Massimo, Lampertico, Pietro
Published in Journal of hepatology (01.11.2023)
Published in Journal of hepatology (01.11.2023)
Get full text
Journal Article